首頁 > 市場調查報告書 > 材料/化學品

包裝/容器醫藥品包裝

市場調查報告書

商品編碼

1804255

醫藥品包裝的全球市場:各包裝形式，各產品，各藥物類型，各處方類型，各最終用途，各地區-市場規模，產業動態，機會分析，預測(2025年～2033年)

Global Pharmaceutical Packaging Market: Packaging Type, Product, Application, Prescription Type, End Use, Region-Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2025-2033

出版日期: 2025年06月30日 | 出版商:

Astute Analytica | 英文 333 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

醫藥包裝是指用於在藥品整個生命週期內進行包裝和保護的材料和工藝。預計2024年醫藥包裝市場規模約為1,770億美元，反映了其在整個醫療保健產業的規模和重要性。預測顯示，未來十年該市場將經歷顯著成長，到2033年將達到6,129億美元。這意味著2025年至2033年的複合年增長率為14.8%，凸顯了該行業的快速擴張和不斷發展變化。

醫藥包裝產業的空前成長是由多種關鍵因素共同推動的，其中最顯著的是全球人口的快速成長和老化，這推動了對各種醫藥產品的需求成長。老年患者通常需要更複雜的治療方案，通常涉及多種藥物，因此需要先進的包裝解決方案來提高安全性、易用性和服藥順從性。此外，糖尿病、心血管疾病和癌症等慢性疾病的發生率不斷上升，也推動了對藥物的持續需求。

值得關注的市場發展

醫藥包裝市場高度分散，既有大型跨國公司，也有中型企業，還有許多規模較小的國內企業。國際紙業、WestRock Company 和 CCL Industries 等公司以提供折疊紙盒和其他二次包裝材料而聞名。這些產品在儲存和運輸過程中保護初級包裝，並向最終消費者提供重要的品牌和監管資訊方面發揮關鍵作用。

該市場近期的策略性舉措顯示了持續的整合和創新。例如，該領域的領導者 Alvotech 宣布收購瑞士 Ivers-Lee 集團，該公司專門從事藥品組裝和包裝服務。此次收購將Ivers-Lee集團的業務策略性地整合到Alvotech的技術營運部門，增強其服務能力，同時保持Ivers-Lee作為獨立法人實體的地位。

市場發展的創新也反映在環保包裝解決方案的開發上。冷鏈技術公司（CCT）近期推出了路邊回收包裹托運人產品組合，專為 "首英里" 包裹運輸而設計。這款新產品確保對溫度敏感的藥品在運輸過程中得到熱保護，這是維持許多藥物療效的關鍵因素。

推動因素

隨著全球65歲及以上人口的快速增長，老齡化社會正在顯著改變醫藥包裝市場。 2024年，該領域人口將達到約7.61億，預計到2050年將翻倍。不斷增長的老齡人口對醫療保健系統提出了巨大的需求，老年人的處方藥消費量通常是年輕人的三倍左右。

輝瑞和諾華等製藥公司強調了這一人口趨勢的經濟影響，並報告稱，專門針對與年齡相關疾病的產品在全球範圍內每年創造約4780億美元的收入。這一巨大的市場價值反映出人們日益關注開發與老化相關的常見疾病的治療方法，例如心血管疾病、關節炎、神經退化性疾病和骨質疏鬆症。

新興市場趨勢

仿製藥徹底改變了新興市場的醫療保健可近性，推動了醫藥包裝市場前所未有的需求。自2020年以來，這些地區約有28億人首次獲得了基本藥物，這主要歸功於仿製藥的廣泛供應和可負擔性。藥物可及性的急劇增加迫使包裝製造商擴大生產規模並創新解決方案，以滿足這個不斷擴大的市場日益多樣化和不斷增長的需求。

印度是全球仿製藥產業的強國，生產約6萬個仿製藥品牌。為了支持如此大規模的生產，每年需要約450億個包裝，以滿足該國龐大的國內人口和國際市場的需求。因此，印度的醫藥包裝產業必須大規模運營，在大批量生產與嚴格的品質和監管標準之間取得平衡，才能安全地將藥品運送到世界各地。

優化障礙

個人化醫療正在從根本上改變藥品製造模式，為醫藥包裝市場帶來新的課題和機會。傳統的大規模、統一的生產方式正在被高度專業化的流程所取代，這些流程必須適應針對個別患者量身定制的小規模生產。在某些情況下，這意味著每批只需生產100個包裝，即可滿足患者獨特治療的精確需求。

這種個人化趨勢在CAR-T細胞療法等先進療法中特別明顯，該療法每年約有15,000名患者獲準。這些療法需要具有低溫儲存功能的個人化包裝解決方案，不僅要確保安全性和有效性，還要保護精密的生物材料。此類專用患者試劑盒的單價可達12,000美元，這反映了其所需的複雜性和精確度。

市場區隔詳情

按包裝類型劃分，初級包裝佔了72%的市場。創新先進包裝增強了初級包裝解決方案的安全性、完整性和功能性，進一步鞏固了這一主導地位。其中最重要的創新之一是溫度指示器的加入，當產品溫度超出關鍵的2-8°C範圍時，它會快速提供視覺提示。這些指示器在暴露於不適當溫度後僅需12秒即可變色，從而可以立即檢測到可能有問題的產品。

依應用劃分，口服藥品包裝佔醫藥包裝市場的主導地位，佔市場收入的33%。其中最顯著的進步之一是配備高靈敏度重量感測器的智慧藥瓶的開發，該感測器可以檢測到藥丸取出，精度高達0.1克。透過追蹤服藥時間和劑量，這些感測器能夠準確監測患者的服藥依從性，從而更好地管理治療方案，尤其對於需要嚴格遵守處方劑量的慢性病患者。

依產品類型劃分，塑膠包裝佔醫藥包裝市場的主導地位，市佔率為36%。這一領先地位主要歸功於多層阻隔膜的突破，這些膜顯著提高了敏感藥品所需的保護性能。這些薄膜的設計旨在實現極低的水蒸氣透過率，通常低於0.0001克/平方公尺/天，有效保護藥品免受濕氣相關的降解。

各市場區隔明細

醫藥品各類型

一級藥物
二級藥物
三級藥物

各產品

瓦楞紙板
- 箱子
- 硬紙盒
- 顯示器個體
紙
- 標籤
- 散頁宣傳印刷品
- 玻璃
安瓿
- 瓶
- 管瓶
- 注射器
- 濾芯
塑膠
- 封口裝置
- 瓶
- 袋子
- 管
- 注入·托盤
- 紙或箔附著層壓板
金屬
- 可折疊管
- 硬質罐
- 鋁箔
- 壓力容器
橡膠

各用途

口服劑
注射劑
外用劑
眼科用藥
經鼻子
舌下
肺
經皮
點滴藥
其他

各處方類型

處方箋
- 品牌藥
- 學名藥
一般用醫藥品
- 品牌藥
- 學名藥

各最終用途

醫藥品製造
受託包裝
零售藥局
機關藥局

各地區

北美
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 波蘭
- 俄羅斯
- 其他
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 澳洲·紐西蘭
- ASEAN
  - 馬來西亞
  - 新加坡
  - 泰國
  - 印尼
  - 菲律賓
  - 越南
  - 其他
- 其他地區
中東·非洲
- 阿拉伯聯合大公國
- 沙烏地阿拉伯
- 南非
- 其他
南美
- 阿根廷
- 巴西
- 其他

各地區明細

北美在醫藥包裝市場佔主導地位，佔41%的市場佔有率，這深深植根於生物技術集群。這些集群是創新中心，包裝製造商和藥品開發商在此密切合作開展研究項目，推動了針對藥品特定需求的尖端包裝解決方案的出現。

這項技術創新的核心是這些集群內的專業測試實驗室，這些實驗室配備了能夠模擬極端條件的先進環境測試室。這些測試室可以重現各種環境，從-80°C的超低溫（如專用冷凍櫃中的溫度）到40°C的高溫和75%的相對濕度。這種能力可以快速、全面地驗證包裝性能，確保藥品在各種儲存和運輸條件下的穩定性和安全性。

對先進製造技術的投資進一步鞏固了北美在該市場的領先地位。僅在2024年，該地區就投資了72億美元，用於升級包裝設施，使其配備最先進的系統。這些技術創新包括基於人工智慧的品質控制系統，其運行速度比傳統的人工檢測快約340倍，顯著提高了缺陷檢測效率。

主要市場參與企業

Amcor
AptarGroup, Inc.
Becton, Dickinson, and Company
Berry Global, Inc.
Catalent (US)
CCL Industries, Inc.
Comar, LLC
Drug Plastics Group
Gerresheimer AG
International Paper
Owens Illinois, Inc.
Schott AG
SGD Pharma
Vetter Pharma International
West Pharmaceutical Services, Inc.
WestRock Company
其他的主要企業

Pharmaceutical packaging refers to the materials and processes utilized to enclose and safeguard medicinal products throughout their entire lifecycle. In 2024, the pharmaceutical packaging market was valued at approximately US$ 177.0 billion, reflecting its significant scale and importance within the broader healthcare industry. Projections indicate that this market will experience remarkable growth over the coming decade, with an anticipated valuation reaching US$ 612.9 billion by 2033. This forecast corresponds to a compound annual growth rate (CAGR) of 14.8% between 2025 and 2033, underscoring the rapid expansion and evolving dynamics within the sector.

The pharmaceutical packaging industry's unprecedented growth is driven by a convergence of several key factors. Foremost among these is the aging global population, which is expanding rapidly and increasing demand for a variety of medications. Older adults typically require more complex treatment regimens, often involving multiple drugs, which necessitates sophisticated packaging solutions designed to enhance safety, usability, and adherence. Additionally, the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and cancer is fueling sustained demand for pharmaceutical products.

Noteworthy Market Developments

The pharmaceutical packaging market is characterized by a high degree of fragmentation, consisting of a diverse mix of large multinational corporations, medium-sized enterprises, and numerous small domestic players. Firms such as International Paper, WestRock Company, and CCL Industries are notable for their offerings in folding cartons and other secondary packaging materials. These products play an essential role in protecting primary packaging during storage and transportation, as well as providing important branding and regulatory information to end consumers.

Recent strategic moves within the market underscore ongoing consolidation and innovation. For example, Alvotech, a key player in the sector, announced its acquisition of Ivers-Lee Group, a Swiss company specializing in pharmaceutical assembly and packaging services. This acquisition strategically integrates Ivers-Lee's operations into Alvotech's Technical Operations division, enhancing its service capabilities while preserving Ivers-Lee as a separate legal entity.

Innovation within the market is also evident in the development of environmentally conscious packaging solutions. Cold Chain Technologies (CCT) recently launched a curbside recyclable parcel shipper portfolio designed specifically for first-mile, parcel-sized shipments. This new product ensures that temperature-sensitive pharmaceutical products remain thermally protected during transit, a critical factor for maintaining the efficacy of many drugs.

Core Growth Drivers

The aging demographic shift is profoundly reshaping the pharmaceutical packaging market, driven by the rapid growth of the global population aged 65 and older. In 2024, this segment reached approximately 761 million individuals, and projections indicate it will double by 2050. This expanding elderly population places significantly greater demands on healthcare systems, as older adults typically consume about three times more prescription medications compared to younger age groups.

Pharmaceutical companies such as Pfizer and Novartis have underscored the economic impact of this demographic trend, reporting that products specifically targeting age-related conditions generate annual revenues of roughly US$ 478 billion globally. This substantial market value reflects the growing focus on developing treatments for diseases commonly associated with aging, including cardiovascular disorders, arthritis, neurodegenerative diseases, and osteoporosis.

Emerging Opportunity Trends

Generic medications have revolutionized healthcare accessibility across emerging markets, driving an unprecedented surge in demand within the pharmaceutical packaging market. Since 2020, approximately 2.8 billion people in these regions have gained first-time access to essential medicines, largely due to the widespread availability and affordability of generic drugs. This dramatic increase in access has created significant pressure on packaging manufacturers to scale up production and innovate solutions that meet the diverse and growing needs of these expanding markets.

India stands as a global powerhouse in the generic pharmaceutical sector, producing an estimated 60,000 generic drug brands. To support this massive output, the country requires around 45 billion packaging units annually, serving both its vast domestic population and international markets. India's pharmaceutical packaging industry must therefore operate on an enormous scale, balancing high-volume production with stringent quality and regulatory standards to ensure the safe delivery of medications worldwide.

Barriers to Optimization

Personalized medicine is fundamentally transforming pharmaceutical manufacturing paradigms, imposing new challenges and opportunities on the pharmaceutical packaging market. Traditional large-scale, uniform production methods are giving way to highly specialized processes that must accommodate small production runs tailored to individual patients. In some cases, this means producing as few as 100 units per batch to meet the precise requirements of patient-specific therapies.

This shift toward personalization is particularly evident in advanced treatments such as CAR-T cell therapies, which have gained approval for around 15,000 patients annually. These therapies necessitate individualized packaging solutions that not only ensure safety and efficacy but also provide cryogenic storage capabilities to maintain the delicate biological materials involved. The cost of these specialized patient kits can reach as high as US$ 12,000 each, reflecting the complexity and precision required.

Detailed Market Segmentation

By Packaging Type, the primary packaging segment holds a commanding 72% share of the market. This dominance is reinforced by revolutionary advancements that enhance the safety, integrity, and functionality of primary packaging solutions. One of the most significant innovations is the integration of embedded temperature indicators that provide rapid visual cues when products experience temperature excursions outside the critical 2-8°C range. These indicators can change color within just 12 seconds of exposure to improper temperatures, allowing for immediate detection of potential product compromise.

By Application, oral drug packaging holds a commanding position in the pharmaceutical packaging market, accounting for 33% of market revenue, largely due to groundbreaking patient-centric innovations. One of the most notable advancements is the development of smart pill bottles equipped with highly sensitive weight sensors capable of detecting medication removal with an accuracy of up to 0.1 grams. These sensors enable precise monitoring of patient adherence by tracking when and how much medication is taken, facilitating better management of treatment regimens, especially for individuals with chronic conditions who require strict adherence to prescribed dosages.

In terms of products, plastic packaging holds a dominant position in the pharmaceutical packaging market, commanding a significant 36% market share. This leadership is largely driven by groundbreaking advancements in multilayer barrier films, which have dramatically improved the protective qualities required for sensitive pharmaceutical products. These films are engineered to achieve exceptionally low water vapor transmission rates, often falling below 0.0001 grams per square meter per day, effectively safeguarding medications from moisture-related degradation.

Segment Breakdown

By Drug Type

Primary
Secondary
Tertiary

By Product

Cardboard
- Boxes
- Cartons
- Display Unit
Paper
- Label
- Leaflet
- Glass
Ampoules
- Bottles
- Vials
- Syringes
- Cartridges
Plastic
- Closure
- Bottles
- Bags
- Tubes
- Injection Trays
- Laminates with paper or foil
Metal
- Collapsible tubes
- Rigid cans
- Foils
- Pressurized containers
Rubber

By Application

Oral Drugs
Injectable
Topical
Ocular/ Ophthalmic
Nasal
Sublingual
Pulmonary
Transdermal
IV Drugs
Others

By Prescription Type

Prescription
- Branded drugs
- Generic drugs
OTC
- Branded drugs
- Generic drugs

By End-Use

Pharma Manufacturing
Contract Packaging
Retail Pharmacy
Institutional Pharmacy

By Region

North America
- The U.S.
- Canada
- Mexico
Europe
- The UK
- Germany
- France
- Italy
- Spain
- Poland
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia & New Zealand
- ASEAN
  - Malaysia
  - Singapore
  - Thailand
  - Indonesia
  - Philippines
  - Vietnam
  - Rest of ASEAN
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
South America
- Argentina
- Brazil
- Rest of South America

Geographical Breakdown

North America's dominance in the pharmaceutical packaging market, commanding a substantial 41% share, is deeply rooted in its concentrated biotechnology clusters. These clusters serve as innovation hubs where packaging manufacturers and drug developers collaborate closely on research initiatives, driving the emergence of cutting-edge packaging solutions tailored to the unique demands of pharmaceutical products.

Central to this innovation are specialized testing laboratories established within these clusters, equipped with advanced environmental chambers capable of simulating extreme conditions. These chambers can replicate environments ranging from ultra-low temperatures of -80°C, akin to those in specialized freezers, to high heat and humidity levels of 40°C and 75% relative humidity. This capability allows for rapid and thorough validation of packaging performance, ensuring that pharmaceutical products remain stable and secure under various storage and transportation conditions.

Investment in advanced manufacturing technologies further strengthens North America's leadership in this market. In 2024 alone, the region saw investments totaling US$ 7.2 billion directed toward upgrading packaging facilities with state-of-the-art systems. Among these innovations are artificial intelligence-powered quality control systems that dramatically enhance defect detection efficiency, operating approximately 340 times faster than traditional manual inspections.

Leading Market Participants

Amcor
AptarGroup, Inc.
Becton, Dickinson, and Company
Berry Global, Inc.
Catalent (US)
CCL Industries, Inc.
Comar, LLC
Drug Plastics Group
Gerresheimer AG
International Paper
Owens Illinois, Inc.
Schott AG
SGD Pharma
Vetter Pharma International
West Pharmaceutical Services, Inc.
WestRock Company
Other Prominent Players

Table of Content

Chapter 1. Research Framework

1.1 Research Objective
1.2 Product Overview
1.3 Market Segmentation

Chapter 2. Research Methodology

2.1 Qualitative Research
- 2.1.1 Primary & Secondary Sources
2.2 Quantitative Research
- 2.2.1 Primary & Secondary Sources
2.3 Breakdown of Primary Research Respondents, By Region
2.4 Assumption for the Study
2.5 Market Size Estimation
2.6. Data Triangulation

Chapter 3. Executive Summary: Global Pharmaceutical Packaging Market

Chapter 4. Global Pharmaceutical Packaging Market Overview

4.1. Industry Value Chain Analysis
- 4.1.1. Raw Material Supplier
- 4.1.2. Manufacturer
- 4.1.3. Processing and Packaging
- 4.1.4. Distributors
- 4.1.5. End User
4.2. Industry Outlook
- 4.2.1. Top pharmaceutical packaging companies and services
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
- 4.4.1. Bargaining Power of Suppliers
- 4.4.2. Bargaining Power of Buyers
- 4.4.3. Threat of Substitutes
- 4.4.4. Threat of New Entrants
- 4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
- 4.5.1. Growth Drivers
- 4.5.2. Restraints
- 4.5.3. Challenges
- 4.5.4. Key Trends
4.6. Covid-19 Impact Assessment on Market Growth Trend
4.7. Market Growth and Outlook
- 4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2020 - 2033
- 4.7.2. Pricing Analysis
4.8. Competition Dashboard
- 4.8.1. Market Concentration Rate
- 4.8.2. Company Market Share Analysis (Value %), 2024
- 4.8.3. Competitor Mapping

Chapter 5. Pharmaceutical Packaging Market, By Packaging Type

5.1. Key Insights
5.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 5.2.1. Primary
- 5.2.2. Secondary
- 5.2.3. Tertiary

Chapter 6. Pharmaceutical Packaging Market, By Product

6.1. Key Insights
6.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 6.2.1. Cardboard

6.2.1.1. Boxes

6.2.1.2. Cartons

6.2.1.3. Display unit

6.2.2. Paper

6.2.2.1. Label

6.2.2.2. Leaflet

6.2.3. Glass

6.2.3.1. Ampoules

6.2.3.2. Bottles

6.2.3.3. Vials

6.2.3.4. Syringes

6.2.3.5. Cartridges

6.2.4. Plastic

6.2.4.1. Closure

6.2.4.2. Bottles

6.2.4.3. Bags

6.2.4.4. Tubes

6.2.4.5. Injection Trays

6.2.4.6. Laminates with paper or foil

6.2.5. Metal

6.2.5.1. Collapsible tubes

6.2.5.2. Rigid cans

6.2.5.3. Foils

6.2.5.4. Pressurized containers

6.2.6. Rubber

Chapter 7. Pharmaceutical Packaging Market, By Drug Type

7.1. Key Insights
7.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 7.2.1. Oral Drugs
- 7.2.2. Injectables
- 7.2.3. Topical
- 7.2.4. Ocular/ Ophthalmic
- 7.2.5. Nasal
- 7.2.6. Sublingual
- 7.2.7. Pulmonary
- 7.2.8. Transdermal
- 7.2.9. IV Drugs
- 7.2.10. Others

Chapter 8. Pharmaceutical Packaging Market, By Prescription Type

8.1. Key Insights
8.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 8.2.1. Prescription
  - 8.2.1.1. Branded Drugs
  - 8.2.1.2. Generic drugs
- 8.2.2. OTC
  - 8.2.2.1. Branded Drugs
  - 8.2.2.2. Generic drugs

Chapter 9. Pharmaceutical Packaging Market, By End Use

9.1. Key Insights
9.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 9.2.1. Pharma Manufacturing
- 9.2.2. Contract Packaging
- 9.2.3. Retail Pharmacy
- 9.2.4. Institutional Pharmacy

Chapter 10. Pharmaceutical Packaging Market, By Region/ Country

10.1. Key Insights
10.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 10.2.1. North America
  - 10.2.1.1. The U.S.
  - 10.2.1.2. Canada
  - 10.2.1.3. Mexico
- 10.2.2. Europe
  - 10.2.2.1. The UK
  - 10.2.2.2 Germany
  - 10.2.2.3 France
  - 10.2.2.4. Spain
  - 10.2.2.5. Italy
  - 10.2.2.6. Russia
  - 10.2.2.7. Poland
  - 10.2.2.8. Rest of Europe
- 10.2.3. Asia Pacific
  - 10.2.3.1. China
  - 10.2.3.2. India
  - 10.2.3.3. Japan
  - 10.2.3.4. Australia & New Zealand
  - 10.2.3.5. ASEAN
  - 10.2.3.6. Rest of Asia Pacific
- 10.2.4. Middle East & Africa (MEA)
  - 10.2.4.1. UAE
  - 10.2.4.2. Saudi Arabia
  - 10.2.4.3. South Africa
  - 10.2.4.4. Rest of MEA
- 10.2.5. South America
  - 10.2.5.1. Brazil
  - 10.2.5.2. Argentina
  - 10.2.5.3. Rest of South America

Chapter 11. North America Pharmaceutical Packaging Market Analysis

11.1. Key Insights
11.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 11.2.1. By Packaging Type
- 11.2.2. By Product Type
- 11.2.3. By Application
- 11.2.4. By End Use
- 11.2.5. By Prescription Type
- 11.2.6. By Country

Chapter 12. The U.S. Pharmaceutical Packaging Market Analysis

12.1. Key Insights
12.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 12.2.1. By Packaging Type
- 12.2.2. By Product Type
- 12.2.3. By Application
- 12.2.4. By End Use
- 12.2.5. By Prescription Type

Chapter 13. Canada Pharmaceutical Packaging Market Analysis

13.1. Key Insights
13.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 13.2.1. By Packaging Type
- 13.2.2. By Product Type
- 13.2.3. By Application
- 13.2.4. By End Use
- 13.2.5. By Prescription Type

Chapter 14. Europe Pharmaceutical Packaging Market Analysis

14.1. Key Insights
14.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 14.2.1. By Packaging Type
- 14.2.2. By Product Type
- 14.2.3. By Application
- 14.2.4. By End Use
- 14.2.5. By Prescription Type
- 14.2.5. By Country

Chapter 15. Asia Pacific Pharmaceutical Packaging Market Analysis

15.1. Key Insights
15.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 15.2.1. By Packaging Type
- 15.2.2. By Product Type
- 15.2.3. By Application
- 15.2.4. By End Use
- 15.2.5. By Prescription Type
- 15.2.6. By Country

Chapter 16. Japan Pharmaceutical Packaging Market Analysis

16.1. Key Insights
16.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 16.2.1. By Packaging Type
- 16.2.2. By Product Type
- 16.2.3. By Application
- 16.2.4. By End Use
- 16.2.4. By Prescription Type

Chapter 17. ASEAN Pharmaceutical Packaging Market Analysis

17.1. Key Insights
17.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 17.2.1. By Packaging Type
- 17.2.2. By Product Type
- 17.2.3. By Application
- 17.2.4. By End Use
- 17.2.5. By Prescription Type
- 17.2.6. By Country

Chapter 18. Middle East & Africa Pharmaceutical Packaging Market Analysis

18.1. Key Insights
18.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 18.2.1. By Packaging Type
- 18.2.2. By Product Type
- 18.2.3. By Application
- 18.2.4. By End Use
- 18.2.5. By Prescription Type
- 18.2.6. By Country

Chapter 19. South America Pharmaceutical Packaging Market Analysis

19.1. Key Insights
19.2. Market Size and Forecast, 2020 - 2033 (US$ Bn)
- 19.2.1. By Packaging Type
- 19.2.2. By Product Type
- 19.2.3. By Application
- 19.2.4. By End Use
- 19.2.5. By Prescription Type
- 19.2.6. By Country